Abiopharma

📋 Douglas Earl Martin (Officer) plans to sell 30K shares of Allogene Therapeutics, Inc. (at $2.12 each, total $63K) Filed: Aug 21, 2026 | ID: 000023

Director Bluestone Jeffrey 🟡 adjusted position in 5.0K shares (2 derivative) of GILEAD SCIENCES, INC. (GILD) at $146.36 ($1.4M) Transaction Date: Aug 20, 2026 | Filing ID: 000005

📋 Lee James CI (Officer) plans to sell 4K shares of Seagate Technology Holdings plc (at $849.35 each, total $3.4M) Filed: Aug 21, 2026 | ID: 000004

Endeavor Blockchain, LLC 🟢 acquired 8.1K shares of Big Digital Energy, Inc. (BGDE) at $7.54 Transaction Date: Aug 20, 2026 | Filing ID: 001145

Stockholder Alert: Robbins LLP Informs Investors of the AEVEX Corp. Class Action

📋 Romano Gianluca (Officer) plans to sell 9K shares of Seagate Technology Holdings plc (at $849.35 each, total $7.8M) Filed: Aug 21, 2026 | ID: 000004

Director Rousseau David 🟢 acquired 1.2K shares of Global Water Resources, Inc. (GWRS) at $8.91 Transaction Date: Aug 19, 2026 | Filing ID: 058499

Director Alexander Richard M 🟡 adjusted position in 735 shares of Global Water Resources, Inc. (GWRS) at $8.91 Transaction Date: Aug 19, 2026 | Filing ID: 058498

Director Steele Christa 🟢 acquired 1.2K shares of Global Water Resources, Inc. (GWRS) at $8.91 Transaction Date: Aug 19, 2026 | Filing ID: 058497

Director Cohn Andrew M. 🟢 acquired 140.1K shares of Global Water Resources, Inc. (GWRS) at $8.91 ($1.2M) Transaction Date: Aug 19, 2026 | Filing ID: 058496

Director Huckelbridge Brett 🟢 acquired 1.0K shares of Global Water Resources, Inc. (GWRS) at $8.91 Transaction Date: Aug 19, 2026 | Filing ID: 058495

📋 Reilly Joseph James (Officer) plans to sell 5K shares of ARDELYX, INC. (at $4.03 each, total $19K) Filed: Aug 21, 2026 | ID: 000006

Baker Cary 🟡 adjusted position in 685 shares (1 derivative) of IMPINJ INC (PI) at $159.73 Transaction Date: Aug 20, 2026 | Filing ID: 000008

Aurora Daljit Singh 🟡 adjusted position in 23.9K shares (6 derivative) of Neumora Therapeutics, Inc. (NMRA) at $1.60 Transaction Date: Aug 20, 2026 | Filing ID: 000385

BERNS PAUL L 🟢 acquired 500.0K shares (1 derivative) of Neumora Therapeutics, Inc. (NMRA) at $1.52 Transaction Date: Aug 20, 2026 | Filing ID: 000384